WELL Health Technologies Corp. (TSX:WELL)
Canada · Delayed Price · Currency is CAD | Market Cap | 1.14B +10.2% |
| Revenue (ttm) | 1.47B +48.9% |
| Net Income | 26.83M |
| EPS | 0.11 |
| Shares Out | 255.41M |
| PE Ratio | 42.39 |
| Forward PE | 19.79 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,162,825 |
| Open | 4.600 |
| Previous Close | 4.550 |
| Day's Range | 4.450 - 4.710 |
| 52-Week Range | 3.580 - 6.080 |
| Beta | 1.33 |
| Analysts | Buy |
| Price Target | 7.03 (+56.92%) |
| Earnings Date | Aug 10, 2026 |
About WELL Health Technologies
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. The company offers omni-channel patient services and solutions to specific markets, such as medical recruitment and staffing, anesthesia, gastrointestinal health, women’s health, primary care, and behavioural health. It also develops, integrates, and sells its own suite of technology software and technology solutions to medical clinics and healthcare practitioners. In addition, the company operates prac... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 13 analysts, the average rating for WELL stock is "Buy." The 12-month stock price target is $7.03, which is an increase of 56.92% from the latest price.
News
WELL Health Provides a Corporate Update on Circle Medical
WELL Health is providing a corporate update on its majority-owned subsidiary Circle Medical, a leading telehealth platform delivering accessible, insurance-based primary care across the United States....
WELL Health Strengthens Clinical and Public Sector Leadership with Appointment of Dr. Andrew Bond as Chief Health Officer and Head of Public Sector
WELL appoints accomplished physician executive and health system leader Dr. Andrew Bond as Chief Health Officer and Head of Public Sector to lead clinical governance and performance, government relati...
Well Health price target raised to C$8.25 from C$8 at Stifel
Stifel raised the firm’s price target on Well Health (WHTCF) to C$8.25 from C$8 and keeps a Buy rating on the shares.
Well Health price target raised to C$6 from C$5.50 at CIBC
CIBC raised the firm’s price target on Well Health (WHTCF) to C$6 from C$5.50 and keeps an Outperformer rating on the shares.
WELL Health Improves Guidance Based on WELL Canada Achieving $100 Million in Annualized Adjusted EBITDA Run-Rate Ahead of Schedule
WELL has reached its goal of $100 million in annualized Adjusted EBITDA(1) run-rate for WELL Canada, three calendar quarters ahead of schedule, driven by strong organic growth across WELL Clinics and ...
WELL Health Announces Appointment of Healthcare Executive Derek Clark as Chief Operating Officer
WELL appoints seasoned healthcare and digital health executive Derek Clark as Chief Operating Officer to support the Company's next phase of operational execution and scale. Mr. Clark brings more than...
WELL Health Announces Approval of Normal Course Issuer Bid
Vancouver, British Columbia--(Newsfile Corp. - May 19, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a digital health company focused on positively impac...
Well Health price target lowered to C$6 from C$6.50 at Scotiabank
Scotiabank lowered the firm’s price target on Well Health (WHTCF) to C$6 from C$6.50 and keeps an Outperform rating on the shares.
WELL Health Technologies Earnings Call Transcript: Q1 2026
Q1 2026 saw 25% revenue growth and 56% adjusted EBITDA growth, with Canadian clinics and technology platforms driving strong results. Guidance for 2026 was reaffirmed, targeting up to CAD 1.65 billion in revenue and significant margin expansion, supported by robust M&A and AI initiatives.
WELL Health Technologies Registration statement: Q1 2026
WELL Health Technologies filed a registration statement on May 7, 2026, providing details about a securities offering with the SEC.
WELL Health Technologies Registration statement: Q1 2026
WELL Health Technologies filed a registration statement on May 7, 2026, providing details about a securities offering with the SEC.
WELL Health Technologies Slides: Q1 2026
WELL Health Technologies has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.
WELL Health Technologies Earnings release: Q1 2026
WELL Health Technologies released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
WELL Health Delivers Record Q1-2026 with Canadian Clinics Run Rate Exceeding $500M and Revenue Up 25% to $368M
WELL achieved quarterly revenues of $368.3 million in Q1-2026, an increase of 25% as compared to Q1-2025 driven by organic growth, acquisitions and the inclusion of HEALWELL results in WELL's consolid...
WELL Health to Announce First Quarter 2026 Financial Results on May 7, 2026
Vancouver, British Columbia--(Newsfile Corp. - April 28, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively...
WELL Health Reports Record Canadian Patient Visits and Primary Care Margin Expansion in Q1-2026
WELL Canada delivered a record ~1.27 million patient visits (1) in Q1-2026, representing 33% year-over-year growth and 13% organic growth, reflecting broad-based strength across its national network. ...
Well Health’s CYBERWELL launches CYDEcore Fusion platform
WELL Health (WHTCF) Technologies announced that its majority-owned subsidiary, CYBERWELL has provided a strategic business update highlighting its unified operating model, proprietary platform capabil...
WELL Subsidiary CYBERWELL Launches CYDEcore Fusion Platform and Provides Strategic Business Update to Address Escalating Cybersecurity Threats
VANCOUVER, British Columbia--(BUSINESS WIRE)--WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) (“WELL”), a digital healthcare company focused on leveraging technology to empower healthcare pra...
WELL Health and WELLSTAR to Participate in Upcoming 2026 Bloom Burton & Co. Healthcare Investor Conference
2026 Bloom Burton & Co. Healthcare Investor Conference on April 21-22, 2026, in Toronto, ON Vancouver, British Columbia--(Newsfile Corp. - April 13, 2026) - WELL Health Technologies Corp. (TSX: WELL) ...
Well Health partners with AliveCor for AI-powered cardiac monitoring
WELL Health (WHTCF) Technologies announced a strategic partnership with AliveCor in which Canadian-registered cardiologists from WELL’s network will provide ECG reviews to Canadian consumers who are u...
WELL Health Partners with AliveCor to Bring AI-Powered Cardiac Monitoring and Cardiologist Oversight to Canadians
VANCOUVER, British Columbia--(BUSINESS WIRE)--WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) (the “Company” or “WELL”), a digital healthcare company focused on positively impacting health ou...
WELL Health Supports Ontario's Commitment to a Provincewide Primary Care Medical Record System
VANCOUVER, British Columbia & TORONTO--(BUSINESS WIRE)--WELL Health Technologies Corp. (TSX: WELL) (the “Company” or “WELL”), a digital healthcare company focused on positively impacting health outcom...
WELL Health Technologies Earnings Call Transcript: Q4 2025
Annual revenue grew 52% to CAD 1.4 billion, with record Adjusted EBITDA and strong free cash flow. Canadian clinics and technology segments drove growth, while U.S. asset divestitures and expanded credit facilities position the company for continued M&A and margin expansion.
WELL Health Technologies Earnings release: Q4 2025
WELL Health Technologies released its Q4 2025 earnings on March 19, 2026, summarizing the period's financial results.
WELL Health Technologies Slides: Q4 2025
WELL Health Technologies has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 19, 2026.